Clean Skincare· India · Updated 12 Oct 2026
Hemangi Dhir
Titan Capital names Hemangi Dhir as Be Clinical's founder and describes a business investing in research, manufacturing and an expanded skincare offering after evolving from Botnal.
Our take
Capital allocated to evidence and production can create operating discipline, but it can also create a cost base that young demand cannot support; sequencing is the founder story.
Background
The August 2026 seed extension is the verified new milestone.
Clinical positioning remains a product-by-product claim to assess; no unsupported biography, education or personal quotation is included.
Philosophy
The useful test is what changed in product development and testing when Botnal became Be Clinical.
Trials that stop a launch can be as informative as those used in marketing.
Career timeline
- Pre-Aug 2026Brand evolves from the earlier Botnal identity.
- 23 Aug 2026INR 21 crore seed extension reported by Titan Capital.
More from the index
Graph relationships
Timeline